PTX-3 has a tendency to rise faster in the pathogenesis of sepsis than the previously used biomarkers and is superior to traditional biomarkers, which may be due to the fact that it is locally produced at the site of infection or tissue damage rather than relying on other molecules to trigger the synthesis of body organs. This evidence concerns the gene PTX3 and Sepsis.